Effect of Bedrest With and Without Exercise on the Heart
Effect of Bedrest With and Without Exercise on Cardiac Atrophy: Synergistic Supplemental Testing With the Cleveland Clinic Bedrest Study
Sponsor: National Space Biomedical Research Institute
Terminated
Main bedrest study moved to Texas. No enrollment at Cleveland Clinic.
This observational or N/A phase trial investigates Bedrest and is currently terminated or withdrawn. National Space Biomedical Research Institute leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Study Description(click to expand)NASA and NSBRI are making considerable investment in a bedrest study being conducted at the Cleveland Clinic Foundation under the directorship of Peter Cavanaugh, primarily to assess the impact of exercise on prevention of osteoporosis in a twelve-week bedrest study to simulate microgravity. This provides an outstanding opportunity for synergistic add-on studies to combine the resources of the bone team of NSBRI with those of the Cardiovascular Alterations and Smart Medicine by conducting a series of detailed echocardiographic and computed tomographic examinations of the heart in these patients. These studies will serve to advance a number of the specific aims of a grant currently held by James D. Thomas from NSBRI concerning both the primary effects of microgravity on the heart and its reversal with exercise as well as the ability to prove out new echocardiographic methods for measuring the cardiac response to exercise. Finally, they will provide an excellent opportunity to prove out methodologies being developed for remote delivery of healthcare by image fusion from free-flight studies to in-flight echoes. We will to pursue the following specific aims with this synergistic study: Specific Aim 1: To assess the impact of bedrest on cardiac atrophy, stiffening of the left ventricular...
NASA and NSBRI are making considerable investment in a bedrest study being conducted at the Cleveland Clinic Foundation under the directorship of Peter Cavanaugh, primarily to assess the impact of exercise on prevention of osteoporosis in a twelve-week bedrest study to simulate microgravity. This provides an outstanding opportunity for synergistic add-on studies to combine the resources of the bone team of NSBRI with those of the Cardiovascular Alterations and Smart Medicine by conducting a series of detailed echocardiographic and computed tomographic examinations of the heart in these patients. These studies will serve to advance a number of the specific aims of a grant currently held by James D. Thomas from NSBRI concerning both the primary effects of microgravity on the heart and its reversal with exercise as well as the ability to prove out new echocardiographic methods for measuring the cardiac response to exercise. Finally, they will provide an excellent opportunity to prove out methodologies being developed for remote delivery of healthcare by image fusion from free-flight studies to in-flight echoes.
We will to pursue the following specific aims with this synergistic study:
Specific Aim 1: To assess the impact of bedrest on cardiac atrophy, stiffening of the left ventricular diastolic pressure volume curve, and exercise tolerance and ventricular mechanics and demonstrate at least partial prevention of these changes with the proposed exercise prescription.
Specific Aim 2: To demonstrate the ability of novel echocardiographic indices of ventricular function (strain, torsion, IVPG) to predict functional capacity and response to exercise.
Specific Aim 3: To test whether pre-bedrest MRI examinations could be co-registered with bedrest 3D echocardiographic exams to track atrophy and altered cardiac anatomy. The ability of detailed 3D ground examinations to be compared precisely with in-flight 3D echos is a key goal of autonomous medical care system for expedition class missions.
Proposed Protocol (summary):
Pre-bedrest (within 1-3 weeks prior):
1. Resting two and three-dimensional echocardiogram. 2. Maximal supine bicycle test with echocardiographic assessment of wall motion, tissue strain, tissue torsion, and intraventricular pressure gradients (IVPG) by color M-mode flow propagation. In addition to the peak exercise assessment, we will also focus on the submaximal level (heart rate \~100). 3. MRI examination of the heart for LV volume and mass and subsequent cross registration with echocardiogram.
Six weeks of bedrest:
1. Resting two and three-dimensional echo exam. 2. Low-level supine bicycle exercise echo (HR no greater than 100) with torsion, strain, and IVPG assessment.
Twelve weeks of bedrest:
1. Resting two and three-dimensional echo. 2. Maximal supine bicycle test with echocardiographic assessment of wall motion, tissue strain, tissue torsion, and IVPG. 3. MRI examination of the heart.
As part of the overall bedrest protocol (IRB 6504), patients will be randomized either to complete bedrest with negative tilt vs. those who will undergo daily horizontal treadmill exercise to replace the calcaneus impact measured pre-bedrest in the same subjects. This provides an excellent opportunity for assessing the impact of this degree in type of exercise on the cardiovascular system.
The specific aims of this synergistic study will be answered as follows:
Specific Aim 1: To assess the impact of bedrest on cardiac atrophy, stiffening of the left ventricular diastolic pressure volume curve, and exercise tolerance and ventricular mechanics and demonstrate at least partial prevention of these changes with the proposed exercise prescription.
LV mass will be measured by MRI pre- and post-bedrest and by 3D echo at bedrest stages. Two-way linear regression will be used to determine change over time in LV mass and to compare the response to exercise. Similarly, exercise capacity will be analyzed. Among the LV mechanics parameters that will be available for analysis at all 3 data acquisition points are: (resting) LV end-diastolic and end-systolic volume, left atrial volume, transmitral E and A waves and E-wave deceleration time, Doppler tissue annular E, A, and S waves, radial, circumferential, and longitudinal strain at the midventricular level, LV torsion and peak untwisting rate, and color M-mode IVPG. These same parameters will also be available for analysis during low-level (HR 100) bicycle exercise.
Specific Aim 2: To demonstrate the ability of novel echocardiographic indices of ventricular function at rest (strain, torsion, IVPG) to predict functional capacity and response to exercise.
Strain, torsion, and IVPG will be assessed at all stages and correlated with changes in cardiac atrophy parameters (LV mass and volumes).
Specific Aim 3: To test whether pre/post bedrest MRI examinations can be co-registered with bedrest 3D echocardiographic exams to track atrophy and altered cardiac anatomy. The ability of detailed 3D ground examinations to be compared precisely with in-flight 3D echos is a key goal of autonomous medical care system for expedition class missions.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Terminated
-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
Feb 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Space Biomedical Research Institute
- The Cleveland Clinic
For direct contact, visit the study record on ClinicalTrials.gov .